I. A. Eliseeva, E. R. Kim, S. G. Guryanov, L. P. Ovchinnikov, and D. N. Lyabin, Y-box-binding protein 1 (YB-1) and its functions, Biochemistry, vol.76, pp.1402-1433, 2011.

D. N. Lyabin, I. A. Eliseeva, and L. P. Ovchinnikov, YB-1 protein: Functions and regulation, Wiley Interdiscip. Rev. RNA, vol.5, pp.95-110, 2014.

M. P. Nekrasov, M. P. Ivshina, K. G. Chernov, E. A. Kovrigina, V. M. Evdokimova et al., The mRNA-binding protein YB-1 (p50) prevents association of the eukaryotic initiation factor eIF4G with mRNA and inhibits protein synthesis at the initiation stage, J. Biol. Chem, vol.278, pp.13936-13943, 2003.

M. A. Skabkin, O. I. Kiselyova, K. G. Chernov, A. V. Sorokin, E. V. Dubrovin et al., Structural organization of mRNA complexes with major core mRNP protein YB-1, Nucleic Acids Res, vol.32, pp.5621-5635, 2004.

V. M. Evdokimova, E. A. Kovrigina, D. V. Nashchekin, E. K. Davydova, J. W. Hershey et al., The major core protein of messenger ribonucleoprotein particles (p50) promotes initiation of protein biosynthesis in vitro, J. Biol. Chem, vol.273, pp.3574-3581, 1998.

S. Wu, X. Fu, J. Huang, T. Jia, F. Zong et al.,

, Genome-wide analysis of YB-1-RNA interactions reveals a novel role of YB-1 in miRNA processing in glioblastoma multiforme, Nucleic Acids Res, vol.43, pp.8516-8528, 2015.

P. S. Suresh, R. Tsutsumi, and T. Venkatesh, YBX1 at the crossroads of non-coding transcriptome, exosomal, and cytoplasmic granular signaling, Eur. J. Cell Biol, vol.97, pp.163-167, 2018.

D. K. Didier, J. Schiffenbauer, S. L. Woulfe, M. Zacheis, and B. D. Schwartz, Characterization of the cDNA encoding a protein binding to the major histocompatibility complex class II Y box, Proc. Natl. Acad. Sci, vol.85, pp.7322-7326, 1988.

O. A. Zasedateleva, A. S. Krylov, D. V. Prokopenko, M. A. Skabkin, L. P. Ovchinnikov et al., Specificity of mammalian Y-box binding protein p50 in interaction with ss and ds DNA analyzed with generic oligonucleotide microchip, J. Mol. Biol, vol.324, pp.73-87, 2002.

D. Dolfini and R. Mantovani, YB-1 (YBX1) does not bind to Y/CCAAT boxes in vivo, Oncogene, vol.32, pp.4189-4190, 2013.

D. Dolfini and R. Mantovani, Targeting the Y/CCAAT box in cancer: YB-1 (YBX1) or NF-Y?, Cell Death Differ, vol.20, pp.676-685, 2013.

T. Soop, D. Nashchekin, J. Zhao, X. Sun, A. T. Alzhanova-ericsson et al., A p50-like Y-box protein with a putative translational role becomes associated with pre-mRNA concomitant with transcription, J. Cell Sci, vol.116, pp.1493-1503, 2003.

E. Stickeler, S. D. Fraser, A. Honig, A. L. Chen, S. M. Berget et al., The RNA binding protein YB-1 binds A/C-rich exon enhancers and stimulates splicing of the CD44 alternative exon v4, EMBO J, vol.20, pp.3821-3830, 2001.

D. O. Watermann, Y. Tang, A. Zur-hausen, M. Jäger, S. Stamm et al., Splicing Factor Tra2-?1 Is Specifically Induced in Breast Cancer and Regulates Alternative Splicing of the CD44 Gene, Cancer Res, vol.66, pp.4774-4780, 2006.

M. Dutertre, G. Sanchez, M. De-cian, J. Barbier, E. Dardenne et al., Cotranscriptional exon skipping in the genotoxic stress response, Nat. Struct. Mol. Biol, vol.17, pp.1358-1366, 2010.

I. Gaudreault, D. Guay, and M. Lebel, YB-1 promotes strand separation in vitro of duplex DNA containing either mispaired bases or cisplatin modifications, exhibits endonucleolytic activities and binds several DNA repair proteins, Nucleic Acids Res, vol.32, pp.316-327, 2004.

E. R. Kim, A. A. Selyutina, I. A. Buldakov, V. Evdokimova, L. P. Ovchinnikov et al., The proteolytic YB-1 fragment interacts with DNA repair machinery and enhances survival during DNA damaging stress, Cell Cycle, vol.12, pp.3791-3803, 2013.

P. Pestryakov, D. O. Zharkov, I. Grin, E. E. Fomina, E. R. Kim et al., Effect of the multifunctional proteins RPA, YB-1, and XPC repair factor on AP site cleavage by DNA glycosylase NEIL1, J. Mol. Recognit, vol.25, pp.224-233, 2012.
URL : https://hal.archives-ouvertes.fr/hal-02292246

E. E. Alemasova, N. A. Moor, K. N. Naumenko, M. M. Kutuzov, M. V. Sukhanova et al., Y-box-binding protein 1 as a non-canonical factor of base excision repair, Biochim. Biophys. Acta Proteins Proteom, vol.1864, pp.1631-1640, 2016.

E. E. Alemasova, K. N. Naumenko, N. A. Moor, and O. I. Lavrik, Y-box-binding protein 1 stimulates abasic site cleavage, vol.82, pp.1521-1528, 2017.

K. Jurchott, S. Bergmann, U. Stein, W. Walther, M. Janz et al., YB-1 as a cell cycle-regulated transcription factor facilitating cyclin A and cyclin B1 gene expression, J. Biol. Chem, vol.278, pp.27988-27996, 2003.

Y. Basaki, F. Hosoi, Y. Oda, A. Fotovati, Y. Maruyama et al., Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells, Oncogene, vol.26, pp.2736-2746, 2007.

K. Higashi, Y. Inagaki, N. Suzuki, S. Mitsui, A. Mauviel et al., Y-box-binding protein YB-1 mediates transcriptional repression of human alpha 2(I) collagen gene expression by interferon-gamma, J. Biol. Chem, vol.278, pp.5156-5162, 2003.

A. V. Sorokin, A. A. Selyutina, M. A. Skabkin, S. G. Guryanov, I. V. Nazimov et al., Proteasome-mediated cleavage of the Y-box-binding protein 1 is linked to DNA-damage stress response, EMBO J, vol.24, pp.3602-3612, 2005.

U. Stein, K. Jürchott, W. Walther, S. Bergmann, P. M. Schlag et al., Hyperthermia-induced nuclear translocation of transcription factor YB-1 leads to enhanced expression of multidrug resistance-related ABC transporters, J. Biol. Chem, vol.276, pp.28562-28569, 2001.

T. Fujita, K. Ito, H. Izumi, M. Kimura, M. Sano et al., Increased nuclear localization of transcription factor Y-box binding protein 1 accompanied by up-regulation of P-glycoprotein in breast cancer pretreated with paclitaxel, Clin. Cancer Res, vol.11, pp.8837-8844, 2005.

R. C. Bargou, K. Jürchott, C. Wagener, S. Bergmann, S. Metzner et al., Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression, Nat. Med, vol.3, pp.447-450, 1997.

K. Matsumoto and B. Bay, Significance of the Y-box proteins in human cancers, J. Mol. Genet. Med, vol.1, pp.11-17, 2005.

C. Kosnopfel, T. Sinnberg, and B. Schittek, Y-box binding protein 1-a prognostic marker and target in tumour therapy, Eur. J. Cell Biol, vol.93, pp.61-70, 2014.

K. Shibahara, K. Sugio, T. Osaki, T. Uchiumi, Y. Maehara et al., Nuclear expression of the Y-box binding protein, YB-1, as a novel marker of disease progression in non-small cell lung cancer, Clin. Cancer Res, vol.7, pp.3151-3155, 2001.

C. R. Van-roeyen, F. G. Scurt, S. Brandt, V. A. Kuhl, S. Martinkus et al., Cold shock Y-box protein-1 proteolysis autoregulates its transcriptional activities, Cell Commun. Signal, vol.63, issue.11, 2013.

A. G. Bader and P. K. Vogt, Inhibition of protein synthesis by Y box-binding protein 1 blocks oncogenic cell transformation, Mol. Cell. Biol, vol.25, pp.2095-2106, 2005.

K. Matsumoto, S. Kose, I. Kuwahara, M. Yoshimura, N. Imamoto et al., Y-box protein-associated acidic protein (YBAP1/C1QBP) affects the localization and cytoplasmic functions of YB-1, Sci. Rep, vol.8, p.6198, 2018.

Y. F. Zhang, C. Homer, S. J. Edwards, L. Hananeia, A. Lasham et al., Nuclear localization of Y-box factor YB1 requires wild-type p53, Oncogene, vol.22, pp.2782-2794, 2003.

B. W. Sutherland, J. Kucab, J. Wu, C. Lee, M. C. Cheang et al., Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells, Oncogene, vol.24, pp.4281-4292, 2005.

L. Prabhu, R. Mundade, B. Wang, H. Wei, A. Hartley et al., Critical role of phosphorylation of serine 165 of YBX1 on the activation of NF-?B in colon cancer, Oncotarget, vol.6, pp.29396-29412, 2015.

M. Martin, L. Hua, B. Wang, H. Wei, L. Prabhu et al., Novel Serine 176 Phosphorylation of YBX1 Activates NF-?B in Colon Cancer, J. Biol. Chem, vol.292, pp.3433-3444, 2017.

V. Evdokimova, P. Ruzanov, M. S. Anglesio, A. V. Sorokin, L. P. Ovchinnikov et al., Akt-mediated YB-1 phosphorylation activates translation of silent mRNA species, Mol. Cell. Biol, vol.26, pp.277-292, 2006.

A. L. Stratford, G. Habibi, A. Astanehe, H. Jiang, K. Hu et al., Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy, Breast Cancer Res, vol.9, 2007.

D. A. Mordovkina, E. R. Kim, I. A. Buldakov, A. V. Sorokin, I. A. Eliseeva et al., Transportin-1-dependent YB-1 nuclear import, Biochem. Biophys. Res. Commun, vol.480, pp.629-634, 2016.

B. J. Lee, A. E. Cansizoglu, K. E. Süel, T. H. Louis, Z. Zhang et al., Rules for nuclear localization sequence recognition by karyopherin beta 2, Cell, vol.126, pp.543-558, 2006.

S. B. Cohen, W. Ma, V. A. Valova, M. Algie, R. Harfoot et al., Genotoxic stress-induced nuclear localization of oncoprotein YB-1 in the absence of proteolytic processing, Oncogene, vol.29, pp.403-410, 2010.

K. Koike, T. Uchiumi, T. Ohga, S. Toh, M. Wada et al., Nuclear translocation of the Y-box binding protein by ultraviolet irradiation, FEBS Lett, vol.417, pp.390-394, 1997.

E. Dahl, A. En-nia, F. Wiesmann, R. Krings, S. Djudjaj et al., Nuclear detection of Y-box protein-1 (YB-1) closely associates with progesterone receptor negativity and is a strong adverse survival factor in human breast cancer, BMC Cancer, vol.9, p.410, 2009.

M. Janz, N. Harbeck, P. Dettmar, U. Berger, A. Schmidt et al., Y-box factor YB-1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1, Int. J. Cancer, vol.97, pp.278-282, 2002.

L. H. Gregersen and J. Q. Svejstrup, The Cellular Response to Transcription-Blocking DNA Damage, Trends Biochem. Sci, vol.43, pp.327-341, 2018.

H. E. Mischo, P. Hemmerich, F. Grosse, and S. Zhang, Actinomycin D induces histone gamma-H2AX foci and complex formation of gamma-H2AX with Ku70 and nuclear DNA helicase II, J. Biol. Chem, vol.280, pp.9586-9594, 2005.

O. Bensaude, Inhibiting eukaryotic transcription: Which compound to choose? How to evaluate its activity? Transcription, vol.2, pp.103-108, 2011.

K. Asakuno, K. Kohno, T. Uchiumi, T. Kubo, S. Sato et al., Involvement of a DNA binding protein, MDR-NF1/YB-1, in human MDR1 gene expression by actinomycin D, Biochem. Biophys. Res. Commun, vol.199, pp.1428-1435, 1994.

T. Tanaka, S. Ohashi, and S. Kobayashi, Four nucleocytoplasmic-shuttling proteins and p53 interact specifically with the YB-NLS and are involved in anticancer reagent-induced nuclear localization of YB-1, Biochem. Biophys. Res. Commun, vol.478, pp.1363-1369, 2016.

D. A. Bushnell, P. Cramer, and R. D. Kornberg, Structural basis of transcription: Alpha-amanitin-RNA polymerase II cocrystal at 2.8 A resolution, Proc. Natl. Acad. Sci, vol.99, pp.1218-1222, 2002.

F. Brueckner and P. Cramer, Structural basis of transcription inhibition by alpha-amanitin and implications for RNA polymerase II translocation, Nat. Struct. Mol. Biol, vol.15, pp.811-818, 2008.

K. G. Chernov, A. Barbet, L. Hamon, L. P. Ovchinnikov, P. A. Curmi et al., Role of microtubules in stress granule assembly: Microtubule dynamical instability favors the formation of micrometric stress granules in cells, J. Biol. Chem, vol.284, pp.36569-36580, 2009.
URL : https://hal.archives-ouvertes.fr/hal-02295275

B. Schwanhäusser, D. Busse, N. Li, G. Dittmar, J. Schuchhardt et al., Global quantification of mammalian gene expression control, Nature, vol.473, pp.337-342, 2011.

W. H. Hudson and E. A. Ortlund, The structure, function and evolution of proteins that bind DNA and RNA, Nat. Rev. Mol. Cell Biol, vol.15, pp.749-760, 2014.

D. A. Kretov, P. A. Curmi, L. Hamon, S. Abrakhi, B. Desforges et al., mRNA and DNA selection via protein multimerization: YB-1 as a case study, Nucleic Acids Res, vol.43, pp.9457-9473, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02183823

S. Saiki, Y. Sasazawa, Y. Imamichi, S. Kawajiri, T. Fujimaki et al., Caffeine induces apoptosis by enhancement of autophagy via PI3K/Akt/mTOR/p70S6K inhibition, Autophagy, vol.7, pp.176-187, 2011.

S. P. Davies, H. Reddy, M. Caivano, and P. Cohen, Specificity and mechanism of action of some commonly used protein kinase inhibitors, Biochem. J, vol.351, pp.95-105, 2000.

T. Conrad, A. Albrecht, V. R. De-melo-costa, S. Sauer, D. Meierhofer et al., Serial interactome capture of the human cell nucleus, Nat. Commun, 2016.

S. Gilbertson, J. D. Federspiel, E. Hartenian, I. M. Cristea, and B. Glaunsinger, Changes in mRNA abundance drive shuttling of RNA binding proteins, linking cytoplasmic RNA degradation to transcription, vol.7, 2018.

T. Tanaka, M. Kasai, and S. Kobayashi, Mechanism responsible for inhibitory effect of indirubin 3 -oxime on anticancer agent-induced YB-1 nuclear translocation in HepG2 human hepatocellular carcinoma cells, Exp. Cell Res, vol.370, pp.454-460, 2018.

J. Yu, J. Zheng, J. Lin, L. Jin, R. Yu et al., Indirubin-3-Oxime Prevents H2O2-Induced Neuronal Apoptosis via Concurrently Inhibiting GSK3? and the ERK Pathway, Cell. Mol. Neurobiol, vol.37, pp.655-664, 2017.

D. R. Marenstein, M. T. Ocampo, M. K. Chan, A. Altamirano, A. K. Basu et al., Stimulation of human endonuclease III by Y box-binding protein 1 (DNA-binding protein B). Interaction between a base excision repair enzyme and a transcription factor, J. Biol. Chem, vol.276, pp.21242-21249, 2001.

T. Ise, G. Nagatani, T. Imamura, K. Kato, H. Takano et al., Transcription factor Y-box binding protein 1 binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen, Cancer Res, vol.59, pp.342-346, 1999.

E. E. Alemasova, K. N. Naumenko, T. A. Kurgina, R. O. Anarbaev, and O. I. Lavrik, The multifunctional protein YB-1 potentiates PARP1 activity and decreases the efficiency of PARP1 inhibitors, Oncotarget, vol.9, pp.23349-23365, 2018.